CCL2 (MCP-1) and its main receptor CCR2 have been widely studied and linked to a host of inflammatory responses including infection, cardiovascular disease, neuro-inflammatory and degenerative disease, autoimmunity, and cancer. This evidence concerns the gene CCL2 and cancer.